360 NEWS360 NEWS
Home / Business

Natco Pharma gets USFDA’s EIR for Visakhapatnam plant

August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated

Published
Original News Source The Hindu BusinessLine
Content & Media Rights The Hindu BusinessLine
Editorial Publisher 360 NEWS (Independent Media)
Natco Pharma gets USFDA’s EIR for Visakhapatnam plant
Photo / Source: The Hindu BusinessLine
August inspection drew four Form-483 observations; regulator classifies as Voluntary Action Indicated
360°

360° PERSPECTIVE

Verified viewpoints, counter-arguments & evidence

Perspective details for this viewpoint are currently being verified by our editorial desk.

Related Stories

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].